Optimized Carbohydrate Fueling to Enhance Physical Performance During Energy Deficit
NCT ID: NCT06394401
Last Updated: 2024-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
12 participants
INTERVENTIONAL
2024-02-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketone Supplements and Substrate Oxidation and Physical Performance
NCT04737694
Dietary Macronutrient Manipulation and Substrate Oxidation During Exercise
NCT02605291
Effects of Severe Negative Energy Balance on Inflammation
NCT03524690
Effects of Acute Carbohydrate Intake Intra-training in Crosstraining
NCT06440343
Effects of a Pre-Workout on Performance, Perceptual Responses, Energy Feelings and Muscular Properties, After a Training Microcycle in Adults.
NCT04147741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Energy Balance: Glucose
Following 48 hours of consuming an energy balance diet, volunteers complete 80 min of steady-state (60 ± 5% V̇O2peak) exercise on a cycle ergometer while consuming 80 g of glucose
BAL:GLU
80 g glucose consumed during steady-state exercise following 48 hours of consuming an energy balance diet
Energy Balance: Glucose plus Fructose
Following 48 hours of consuming an energy balance diet, volunteers complete 80 min of steady-state (60 ± 5% V̇O2peak) exercise on a cycle ergometer while consuming 53 g of glucose and 27 g of fructose.
BAL:GLU+FRU
53 g glucose plus 27 g fructose consumed during steady-state exercise following 48 hours of consuming an energy balance diet
Energy Deficit: Glucose
Following 48 hours of consuming an energy deficit diet, volunteers complete 80 min of steady-state (60 ± 5% V̇O2peak) exercise on a cycle ergometer while consuming 80 g of glucose
DEF:GLU
80 g glucose consumed during steady-state exercise following 48 hours of consuming an energy balance diet
Energy Deficit: Glucose plus Fructose
Following 48 hours of consuming an energy deficit diet, volunteers complete 80 min of steady-state (60 ± 5% V̇O2peak) exercise on a cycle ergometer while consuming 53 g of glucose and 27 g of fructose.
DEF:GLU+FRU
53 g glucose plus 27 g fructose consumed during steady-state exercise following 48 hours of consuming an energy balance diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BAL:GLU
80 g glucose consumed during steady-state exercise following 48 hours of consuming an energy balance diet
BAL:GLU+FRU
53 g glucose plus 27 g fructose consumed during steady-state exercise following 48 hours of consuming an energy balance diet
DEF:GLU
80 g glucose consumed during steady-state exercise following 48 hours of consuming an energy balance diet
DEF:GLU+FRU
53 g glucose plus 27 g fructose consumed during steady-state exercise following 48 hours of consuming an energy balance diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy without evidence of chronic illness or musculoskeletal injury as determined by the USARIEM Office of Medical Support and Oversight (OMSO) or home duty station medical support
* Routinely participate in aerobic and/or resistance exercise at least 2 days per week
* Willing to refrain from alcohol, smoking/using any nicotine product (includes e-cigarettes, vaping, chewing tobacco), caffeine, and dietary supplements while consuming the study diet
* Supervisor approval for federal civilian employees and non-HRV active duty military personnel
* Females must have normal menstrual cycles between 26-32 days in duration; 5 menstrual cycles within the past 6 months; or on continuous oral or IUD contraception without placebo.
Exclusion Criteria
* Metabolic or cardiovascular abnormalities, gastrointestinal disorders (e.g., kidney disease, diabetes, cardiovascular disease, etc.), claustrophobia
* Significantly abnormal blood clotting as determined by OMSO or home duty station medical support
* Allergy to lidocaine (or similar local anesthetic)
* Present condition of alcoholism, anabolic steroid use, or other substance abuse issues as determined by OMSO or home duty station medical support
* Blood donation within 8-wk of beginning the study
* Pregnant, trying to become pregnant, and/or breastfeeding (results of urine pregnancy test and self-report for breastfeeding will be obtained before body composition testing)
* Unwilling or unable to consume study diets or foods provided due to personal preference, dietary restrictions, and/or food allergies
* Unwilling or unable to adhere to study physical restrictions
18 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Army Research Institute of Environmental Medicine
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USARIEM
Natick, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-15H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.